Evaluation of the BH3-only protein Puma as a direct Bak activator

Journal of Biological Chemistry

Volumn 289, Issue 1, 2014, Pages 89-99

  Dai, Haiming ^a   Pang, Yuan Ping ^b   Ramirez Alvarado, Marina ^b   Kaufmann, Scott H ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; LIPOSOMES; OLIGOMERIZATION; OLIGOMERS;

BCL-2 FAMILY PROTEINS; CELL VIABILITY; CELLULAR CONTEXTS; FULL-LENGTH PROTEINS; IMMUNOBLOTTING; LIFE AND DEATH; MEMBRANE PERMEABILIZATION; PERMEABILIZATION;

PROTEINS;

BH3 PROTEIN; BIM PROTEIN; LIPOSOME; PROTEIN BAK; PROTEIN NOXA; PUMA PROTEIN; APOPTOSIS REGULATORY PROTEIN; BAK1 PROTEIN, HUMAN; BAK1 PROTEIN, MOUSE; BBC3 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN BINDING; PUMA PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; IMMUNOBLOTTING; MEMBRANE PERMEABILITY; MITOCHONDRION; MUTATION RATE; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; WILD TYPE; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CELL LINE; CELL SURVIVAL; HUMANS; LIPOSOMES; MICE; MITOCHONDRIA; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84891698320     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.505701     Document Type: Article

References (79)

1. Wyllie, A. H., Kerr, J. F., and Currie, A. R. (1980) Cell death. The significance of apoptosis. Int. Rev. Cytol. 68, 251-306
2. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462
3. Adjei, P. N., Kaufmann, S. H., Leung, W. Y., Mao, F., and Gores, G. J. (1996) Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors. Evidence for a protease-dependent pathway that does not activate CPP32. J Clin. Invest. 98, 2588-2596 (Pubitemid 26415080)
4. Kroemer, G., and Martin, S. J. (2005) Caspase-independent cell death. Nat. Med. 11, 725-730
5. Tait, S. W., and Green, D. R. (2008) Caspase-independent cell death. Leaving the set without the final cut. Oncogene 27, 6452-6461
6. Earnshaw, W. C., Martins, L. M., and Kaufmann, S. H. (1999) Mammalian caspases. Structure, Activation, Substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424 (Pubitemid 29449198)
7. Creagh, E. M., and Martin, S. J. (2001) Caspases. Cellular demolition experts. Biochem. Soc. Trans. 29, 696-702
8. Walczak, H., and Krammer, P. H. (2000) The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256, 58-66 (Pubitemid 30211167)
9. Debatin, K. M., and Krammer, P. H. (2004) Death receptors inchemotherapy and cancer. Oncogene 23, 2950-2966
10. Schütze, S., Tchikov, V., and Schneider-Brachert, W. (2008) Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat. Rev. Mol. Cell Biol. 9, 655-662 (Pubitemid 352032925)
11. Johnstone, R. W., Frew, A. J., and Smyth, M. J. (2008) The TRAIL apoptotic pathway in cancer onset, progression, and therapy. Nat. Rev. Cancer 8, 782-798
12. Abdulghani, J., and El-Deiry, W. S. (2010) TRAIL receptor signaling and therapeutics. Expert. Opin. Ther. Targets 14, 1091-1108
13. Afonina, I. S., Cullen, S. P., and Martin, S. J. (2010) Cytotoxic and noncytotoxic roles of the CTL/NK protease granzyme B. Immunol. Rev. 235, 105-116
14. Ewen, C. L., Kane, K. P., and Bleackley, R. C. (2012) A quarter century of granzymes. Cell Death Differ. 19, 28-35
15. Jiang, X., and Wang, X. (2004) Cytochrome c-mediated apoptosis. Annu. Rev. Biochem. 73, 87-106 (Pubitemid 39050364)
16. Taylor, R. C., Cullen, S. P., and Martin, S. J. (2008) Apoptosis. Controlled demolition at the cellular level. Nat Rev. Mol. Cell Biol. 9, 231-241 (Pubitemid 351301823)
17. Tait, S. W., and Green, D. R. (2010) Mitochondria and cell death. Outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621-632
18. Strasser, A., Cory, S., and Adams, J. M. (2011) Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBOJ. 30, 3667-3683
19. Letai, A. G. (2008) Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev. Cancer 8, 121-132 (Pubitemid 351161322)
20. Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., and Green, D. R. (2010) The BCL-2 family reunion. Mol. Cell 37, 299-310
21. Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., and Korsmeyer, S. J. (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183-192 (Pubitemid 41043974)
22. Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., and Newmeyer, D. D. (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342 (Pubitemid 35341388)
23. Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., and Newmeyer, D. D. (2005) BH3 Domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 17, 525-535 (Pubitemid 40269117)
24. Fadeel, B., Zhivotovsky, B., and Orrenius, S. (1999) All along the watchtower. On the regulation of apoptosis regulators. FASEB J. 13, 1647-1657 (Pubitemid 29473328)
25. Chipuk, J. E., and Green, D. R. (2008) How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18, 157-164
26. Mérino, D., Giam, M., Hughes, P. D., Siggs, O. M., Heger, K., O'Reilly, L. A., Adams, J. M., Strasser, A., Lee, E. F., Fairlie, W. D., and Bouillet, P. (2009) The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins. J. Cell Biol. 186, 355-362
27. Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., and Vogelstein, B. (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673-682 (Pubitemid 32706358)
28. Nakano, K., and Vousden, K. H. (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694 (Pubitemid 32706359)
29. Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., and Strasser, A. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036-1038 (Pubitemid 37386194)
30. Jeffers, J. R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J., MacLean, K. H., Han, J., Chittenden, T., Ihle, J. N., McKinnon, P. J., Cleveland, J. L., and Zambetti, G. P. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321-328 (Pubitemid 37329796)
31. Yu, J., Wang, Z., Kinzler, K. W., Vogelstein, B., and Zhang, L. (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100, 1931-1936 (Pubitemid 36254551)
32. Erlacher, M., Michalak, E. M., Kelly, P. N., Labi, V., Niederegger, H., Coultas, L., Adams, J. M., Strasser, A., and Villunger, A. (2005) BH3-only proteins Puma and Bim are rate-limiting for 7-radiation- and glucocorticoidinduced apoptosis of lymphoid cells in vivo. Blood 106, 4131-4138 (Pubitemid 41775918)
33. Erlacher, M., Labi, V., Manzl, C., Böck, G., Tzankov, A., Häcker, G., Michalak, E., Strasser, A., and Villunger, A. (2006) Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J. Exp. Med. 203, 2939-2951 (Pubitemid 46026171)
34. Michalak, E. M., Villunger, A., Adams, J. M., and Strasser, A. (2008) In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15, 1019-1029 (Pubitemid 351712606)
35. Qiu, W., Carson-Walter, E. B., Liu, H., Epperly, M., Greenberger, J. S., Zambetti, G. P., Zhang, L., and Yu, J. (2008) PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2, 576-583 (Pubitemid 351729214)
36. Happo, L., Cragg, M. S., Phipson, B., Haga, J. M., Jansen, E. S., Herold, M. J., Dewson, G., Michalak, E. M., Vandenberg, C. J., Smyth, G. K., Strasser, A., Cory, S., and Scott, C. L. (2010) Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. Blood 116, 5256-5267
37. Yu, H., Shen, H., Yuan, Y., Xu Feng, R., Hu, X., Garrison, S. P., Zhang, L., Yu, J., Zambetti, G. P., and Cheng, T. (2010) Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose 7-irradiation. Blood 115, 3472-3480
38. Kerr, J. B., Hutt, K. J., Michalak, E. M., Cook, M., Vandenberg, C. J., Liew, S. H., Bouillet, P., Mills, A., Scott, C. L., Findlay, J. K., and Strasser, A. (2012) DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol. Cell 48, 343-352
39. Ekert, P. G., Jabbour, A. M., Manoharan, A., Heraud, J. E., Yu, J., Pakusch, M., Michalak, E. M., Kelly, P. N., Callus, B., Kiefer, T., Verhagen, A., Silke, J., Strasser, A., Borner, C, and Vaux, D. L. (2006) Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase but depends in part on Puma. Blood 108, 1461-1468 (Pubitemid 44316109)
40. Ekoff, M., Kaufmann, T., Engström, M., Motoyama, N., Villunger, A., Jönsson, J. I., Strasser, A., and Nilsson, G. (2007) The BH3-only protein Puma plays an essential role in cytokine deprivation induced apoptosis of mast cells. Blood 110, 3209-3217 (Pubitemid 350106313)
41. Jabbour, A. M., Daunt, C. P., Green, B. D., Vogel, S., Gordon, L., Lee, R. S., Silke, N., Pearson, R. B., Vandenberg, C. J., Kelly, P. N., Nutt, S. L., Strasser, A., Borner, C, and Ekert, P. G. (2010) Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation. Blood 115, 344-352
42. Garrison, S. P., Jeffers, J. R., Yang, C., Nilsson, J. A., Hall, M. A., Rehg, J. E., Yue, W., Yu, J., Zhang, L., Onciu, M., Sample, J. T., Cleveland, J. L., and Zambetti, G. P. (2008) Selection against PUMA gene expression in Mycdriven B-cell lymphomagenesis. Mol. Cell Biol. 28, 5391-5402
43. Michalak, E. M., Jansen, E. S., Happo, L., Cragg, M. S., Tai, L., Smyth, G. K., Strasser, A., Adams, J. M., and Scott, C. L. (2009) Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ. 16, 684-696
44. Bean, G. R., Ganesan, Y. T., Dong, Y., Takeda, S., Liu, H., Chan, P. M., Huang, Y., Chodosh, L. A., Zambetti, G. P., Hsieh, J. J., and Cheng, E. H. (2013) PUMA and BIM are required for oncogene inactivation-induced apoptosis. Sci. Signal. 6, ra20
45. Concannon, C. G., Koehler, B. F., Reimertz, C., Murphy, B. M., Bonner, C., Thurow, N., Ward, M. W., Villunger, A., Strasser, A., Kögel, D., and Prehn, J. H. (2007) Apoptosis induced by proteasome inhibition in cancer cells. Predominant role of the p53/PUMA pathway. Oncogene 26, 1681-1692 (Pubitemid 46426201)
46. Steckley, D., Karajgikar, M., Dale, L. B., Fuerth, B., Swan, P., Drummond-Main, C., Poulter, M. O., Ferguson, S. S., Strasser, A., and Cregan, S. P. (2007) Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis. J. Neurosci. 27, 12989-12999 (Pubitemid 350159577)
47. Ghosh, A. P., Walls, K. C., Klocke, B. J., Toms, R., Strasser, A., and Roth, K. A. (2009) The proapoptotic BH3-only, Bcl-2 family member, Puma is critical for acute ethanol-induced neuronal apoptosis. J. Neuropathol. Exp. Neurol. 68, 747-756
48. Bernstein, A. I., Garrison, S. P., Zambetti, G. P., and O'Malley, K. L. (2011) 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Mol. Neurodegener. 6, 2
49. Fischer, S. F., Belz, G. T., and Strasser, A. (2008) BH3-only protein Puma contributes to death of antigen-specific T cells during shutdown of an immune response to acute viral infection. Proc. Natl. Acad. Sci. U. S. A. 105, 3035-3040 (Pubitemid 351723663)
50. Clybouw, C., Fischer, S., Auffredou, M. T., Hugues, P., Alexia, C., Bouillet, P., Raphael, M., Leca, G., Strasser, A., Tarlinton, D. M., and Vazquez, A. (2011) Regulation of memory B-cell survival by the BH3-only protein Puma. Blood 118, 4120-4128
51. Gray, D. H., Kupresanin, F., Berzins, S. P., Herold, M. J., O'Reilly, L. A., Bouillet, P., and Strasser, A. (2012) The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens. Immunity 37, 451-462
52. Ren, D., Tu, H. C., Kim, H., Wang, G. X., Bean, G. R., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J., and Cheng, E. H. (2010) BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330, 1390-1393
53. Jabbour, A. M., Heraud, J. E., Daunt, C. P., Kaufmann, T., Sandow, J., O'Reilly, L. A., Callus, B. A., Lopez, A., Strasser, A., Vaux, D. L., and Ekert, P. G. (2009) Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim. Cell Death Differ. 16, 555-563
54. Chipuk, J. E., and Green, D. R. (2009) PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis. Cell Cycle 8, 2692-2696
55. Follis, A. V., Chipuk, J. E., Fisher, J. C., Yun, M. K., Grace, C. R., Nourse, A., Baran, K., Ou, L., Min, L., White, S. W., Green, D. R., and Kriwacki, R. W. (2013) PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis. Nat. Chem. Biol. 9, 163-168
56. Gallenne, T., Gautier, F., Oliver, L., Hervouet, E., Noël, B., Hickman, J. A., Geneste, O., Cartron, P. F., Vallette, F. M., Manon, S., and Juin, P. (2009) Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J. Cell Biol. 185, 279-290
57. Kim, H., Tu, H. C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J., and Cheng, E. H. (2009) Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell 36, 487-499
58. Edwards, A. L., Gavathiotis, E., La Belle, J. L., Braun, C. R., Opoku-Nsiah, K. A., Bird, G. H., and Walensky, L. D. (2013) Multimodal interaction with BCL-2 family proteins underlies the proapoptotic activity of PUMA BH3. Chem. Biol. 20, 888-902
59. Zhang, Y., Xing, D., and Liu, L. (2009) PUMA promotes Bax translocation by both directly interacting with Bax and by competitive binding to Bcl-X L during UV-induced apoptosis. Mol. Biol. Cell 20, 3077-3087
60. Vela, L., Gonzalo, O., Naval, J., and Marzo, I. (2013) Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation. J. Biol. Chem. 288, 4935-4946
61. Du, H., Wolf, J., Schafer, B., Moldoveanu, T., Chipuk, J. E., and Kuwana, T. (2011) BH3 domains other than Bim and Bid can directly activate Bax/Bak. J. Biol. Chem. 286, 491-501
62. Dai, H., Smith, A., Meng, X. W., Schneider, P. A., Pang, Y.-P., and Kaufmann, S. H. (2011) Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization. J. Cell Biol. 194, 39-48
63. Czabotar, P. E., Westphal, D., Dewson, G., Ma, S., Hockings, C., Fairlie, W. D., Lee, E. F., Yao, S., Robin, A. Y., Smith, B. J., Huang, D. C., Kluck, R. M., Adams, J. M., and Colman, P. M. (2013) Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell 152, 519-531
64. Hackbarth, J. S., Lee, S.-H., Meng, X. W., Vroman, B. T., Kaufmann, S. H., and Karnitz, L. M. (2004) S-peptide epitope tagging for protein purification, expression monitoring and localization in mammalian cells. Bio-Techniques 37, 835-839 (Pubitemid 39488463)
65. Moldoveanu, T., Liu, Q., Tocilj, A., Watson, M., Shore, G., and Gehring, K. (2006) The X-ray structure of a BAK homodimer revealsan inhibitory zinc binding site. Mol. Cell 24, 677-688 (Pubitemid 44839210)
66. Oh, K. J., Singh, P., Lee, K., Foss, K., Lee, S., Park, M., Lee, S., Aluvila, S., Park, M., Singh, P., Kim, R. S., Symersky, J., and Walters, D. E. (2010) Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J. Biol. Chem. 285, 28924-28937
67. Goping, I. S., Gross, A., Lavoie, J. N., Nguyen, M., Jemmerson, R., Roth, K., Korsmeyer, S. J., and Shore, G. C. (1998) Regulated targeting of BAX to mitochondria. J. Cell Biol. 143, 207-215 (Pubitemid 28480529)
68. Meng, X. W., Lee, S. H., Dai, H., Loegering, D., Yu, C., Flatten, K., Schneider, P., Dai, N. T., Kumar, S. K., Smith, B. D., Karp, J. E., Adjei, A. A., and Kaufmann, S. H. (2007) Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis. A mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. J. Biol. Chem. 282, 29831-29846 (Pubitemid 350035287)
69. Mesa, R. A., Loegering, D., Powell, H. L., Flatten, K., Arlander, S. J., Dai, N. T., Heldebrant, M. P., Vroman, B. T., Smith, B. D., Karp, J. E., Eyck, C. J., Erlichman, C., Kaufmann, S. H., and Karnitz, L. M. (2005) Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine. Blood 106, 318-327 (Pubitemid 40967208)
70. Pang, Y. P., Dai, H., Smith, A., Meng, X. W., Schneider, P. A., and Kaufmann, S. H. (2012) Bak conformational changes induced by ligand binding. Insight into BH3 domain binding and Bak homo-oligomerization. Sci. Rep. 2, 257
71. Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., and Simmerling, C. (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65, 712-725 (Pubitemid 44583220)
72. Wickstrom, L., Okur, A., and Simmerling, C. (2009) Evaluating the performance of the ff99SB force field based on NMR scalar coupling data. Biophys. J. 97, 853-856
73. Berendsen, H. J. C., Postma, J. P. M., Van Gunsteren, W. F., Di Nola, A., and Haak, J. R. (1984) Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684-3690
74. Darden, T. A., York, D. M., and Pedersen, L. G. (1993) Particle Mesh Ewald. An N log (N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092
75. Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H. C., Kim, H., Cheng, E. H., Tjandra, N., and Walensky, L. D. (2008) BAX activation is initiated at a novel interaction site. Nature 455, 1076-1081
76. Dewson, G., Kratina, T., Sim, H. W., Puthalakath, H., Adams, J. M., Colman, P. M., and Kluck, R. M. (2008) To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3. Groove interactions. Mol. Cell 30, 369-380 (Pubitemid 351626944)
77. Killian, B. J., Kravitz, J. Y., Somani, S., Dasgupta, P., Pang, Y. P., and Gilson, M. K. (2009) Configurational entropy in protein-peptide binding. Computational study of Tsg101 ubiquitin E2 variant domain with an HIV-derived PTAP nonapeptide. J. Mol. Biol. 389, 315-335
78. Dai, H., Meng, X. W., Lee, S.-H., Schneider, P. A., and Kaufmann, S. H. (2009) Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis. J. Biol. Chem. 284, 18311-18322
79. Ding, H., Hackbarth, J., Schneider, P. A., Peterson, K. L., Meng, X. W., Dai, H., Witzig, T. E., and Kaufmann, S. H. (2011) Cytotoxicity offarnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim upregulation. Blood 118, 4872-4881